BRIEF-FTC approves final order settling charges for Boehringer Ingelheim’s asset swap with Sanofi
February 24, 2017 at 13:54 PM EST
* U.S. FTC - Approved final order settling charges that Boehringer Ingelheim’s $13.53 billion asset swap with Sanofi would likely be anticompetitive Source text : (http://bit.ly/2lC10ws) Further company coverage:
